Announcement date: 2021-05-10

The Institute of Psychiatry and Neurology in Warsaw, as a potential Consortium Leader, announces an open recruitment for the Consortium to implement a research project in the therapeutic area of ​​multiple sclerosis treatment as part of the Medical Research Agency's competition for non-commercial clinical trials in the area of ​​psychiatry and neurology. Competition number: ABM/2021/2.

Competition regulations: https://abm.gov.pl/pl/konkursy/aktualne-nabory-1/807,Konkurs-na-niekomercyjne-badania-kliniczne-w-psychiatrii-i-neurologii-ABM20212.html

Recruitment for the Consortium is open to institutions that meet the competition regulations, have a team, infrastructure and experience in the diagnosis and treatment of multiple sclerosis and will be able to ensure the implementation of the project tasks.

The task of the Consortium will be to conduct a randomized, placebo-controlled, double-blind, parallel-group clinical trial aimed at demonstrating the effectiveness and safety of the medicinal product indicated by the Consortium Leader in the treatment of secondary progressive sclerosis.

In order to implement the project's tasks, we are looking for centers with equipment and experience in performing the following tests:

1. Magnetic resonance imaging of the head and core at least 3T with examination of the number and volume of damage foci (T2+) and the volume of selected structures of the central nervous system, and with QSM imaging
2. Performing tests for protein markers of the inflammatory reaction in blood serum and cerebrospinal fluid

Detailed information about the planned research project can be obtained from Prof. Iwona Kurkowska-Jastrzębska, e-mail: ikurkowska@ipin.edu.pl, tel. 22-4582-537.

The deadline for registering willingness to participate in the consortium is 14 days from the date of announcement of the recruitment on the website of the Institute of Psychiatry and Neurology in Warsaw, i.e. May 24, 2021.

The notification should include the following information:

– description of the institution's experience in diagnosing and treating multiple sclerosis, also in conducting clinical research in this area, or experience in conducting scientific research in the field of basic and/or clinical research of the nervous system,

– description of diagnostic and research equipment required to conduct a clinical trial,

– proposed researcher, providing his or her contact details.

In the event of a larger number of consortium members than expected in the competition regulations (i.e. more than three), the Institute of Psychiatry and Neurology will select an institution to join the Consortium based on the competition regulations in accordance with the principles of transparency and equal treatment, taking into account the compliance of the potential Consortium member's activities with the declared goals of the Consortium. the contribution of the potential Consortium Member to the achievement of the Consortium's goal, experience in the implementation of clinical trials in the therapeutic indication of multiple sclerosis.

News about the results of the open recruitment of Consortium Members, including information about the entities selected to serve as Consortium Members, will be announced on the website of the Institute of Psychiatry and Neurology on May 28, 2021.

Applications should be submitted by e-mail to the following address: ikurkowska@ipin.edu.pl ; in the title you should write: COMPETITION ABM/2021/2